United Therapeutics reported $109.1M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Amarin AMRN:US 102.96M 4.24M
Ardelyx ARDX:US $ 17.31M 2.81M
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Baxter International BAX:US $ 630M 18M
Bayer BAYN:GR 3.77B 19M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Emergent Biosolutions EBS:US $ 82.1M 9.1M
Esperion Therapeutics ESPR:US $ 39.26M 7.05M
Gilead Sciences GILD:US $ 1.18B 173M
GlaxoSmithKline GSK:LN 2.5B 6M
Halozyme Therapeutics HALO:US $ 13.17M 848K
Insmed INSM:US $ 60.28M 3.1M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Johnson & Johnson JNJ:US $ 6B 73M
Lexicon Pharmaceuticals LXRX:US 7.3M 633K
Moderna Inc MRNA:US 168M 47M
Omeros OMER:US $ 20.86M 699K
Pfizer PFE:US $ 2.73B 61M
Ptc Therapeutics PTCT:US $ 69.25M 374K
Regeneron Pharmaceuticals REGN:US $ 445M 30.3M
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Teva Pharmaceutical TEVA:IT 864M 32M
United Therapeutics UTHR:US $ 109.1M 3.7M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M